Patents by Inventor Simon Mark Lumb

Simon Mark Lumb has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Human phosphodiesterase type IVC, and its production and use
    Patent number: 6291199
    Abstract: Recombinant human phosphodiesterase type IVC is described, and DNA coding for it. Particular conformers of the enzyme are identified, including a R- and S-rolipram stereoselective conformer which is obtainable by expression of human phosphodiesterase type IVC DNA in mammalian or insect cells. The recombinant enzyme may be used in a screen to select a compound capable of modulating the action of the enzyme, or as an immunogen to generate an antibody.
    Type: Grant
    Filed: May 15, 1998
    Date of Patent: September 18, 2001
    Assignee: Celltech Therapeutics Limited
    Inventors: Raymond John Owens, Martin John Perry, Simon Mark Lumb
  • Human phosphodiesterase type IVC, and its production and use
    Patent number: 5851784
    Abstract: Recombinant human phosphodiesterase type IVC is described, and DNA coding for it. Particular conformers of the enzyme are identified, including a R- and S-rolipram stereoselective conformer which is obtainable by expression of human phosphodiesterase type IVC DNA in mammalian or insect cells. The recombinant enzyme may be used in a screen to select a compound capable of modulating the action of the enzyme, or as an immunogen to generate an antibody.
    Type: Grant
    Filed: December 22, 1995
    Date of Patent: December 22, 1998
    Assignee: Celltech Therapeutics, Limited
    Inventors: Raymond John Owens, Martin John Perry, Simon Mark Lumb